Evidence map›Paper›PMID 41724854›Full record

ArticleMikrochimica acta2026

Exploring the potential of β-Cyclodextrin@Ti

Sevda Hasanova, Eda Gumus, Serdar Akbayrak, Erhan Zor

Abstract read
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sevda HasanovaDepartment of Nanoscience and Nanoengineering, Institute of Science, Necmettin Erbakan University, Konya, 42090, Türkiye.
Eda GumusScience and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, 42140, Türkiye.
Serdar AkbayrakScience and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, 42140, Türkiye. serdarakbayrak.rg@gmail.com.
Erhan ZorScience and Technology Research and Application Center (BITAM), Necmettin Erbakan University, Konya, 42140, Türkiye. zorerhan@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An electrochemical chiral sensor based on β-cyclodextrin@Ti3C2Tx MXene/screen printed carbon electrode (β-CD@MXene/SPCE) was developed for the determination of D- and L-tyrosine enantiomers for the first time. Morphological characterization of the material (β-CD@MXene) was performed using Field Emission-Scanning Electron Microscopy (FE-SEM) and Transmission Electron Microscopy (TEM) imaging, while X-ray Diffraction (XRD) and Fourier Transform Infrared Spectroscopy (FTIR) confirmed the crystalline structure and interaction between MXene and β-CD in structural characterization. To evaluate the electrochemical characterization of the modified electrodes, cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques were applied. To investigate the electrochemical behavior of the tested D- and L-amino acid enantiomers, CV and differential pulse voltammetry (DPV) techniques were conducted. Among the tested chiral species, only D- and L-tyrosine showed distinct voltammetric signals. To investigate the electrochemical behavior of D- and L-tyrosine, CV and DPV techniques were conducted revealing an increase in oxidation peak currents with the increasing tyrosine concentration levels. The voltammetric response of racemic D/L-tyrosine was also examined. For real sample analysis, human serum was used in chronoamperometric measurements (10–100 µM), yielding a linear response. The LOD and LOQ values were 3.15 µM and 9.45 µM, respectively, for D-tyrosine, and 4.68 µM and 14.05 µM, respectively, for L-tyrosine in human serum samples.

Indexed as

Chiral recognitionChronoamperometryElectrochemical sensorEnantiomerMXeneScreen printed carbon electrodeTyrosineVoltammetryβ-Cyclodextrin

Identifiers

PMID41724854
PMCPMC12926242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.